Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention

Published:2012-09-22 Issue:4 Volume:69 Page:771-777
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Zou Jian-Jun,Xie Hong-Guang,Chen Shao-Liang,Tan Jie,Lin Ling,Zhao Ying-Ying,Xu Hai-Mei,Lin Song,Zhang Juan,Wang Guang-Ji

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-012-1392-5.pdf

Reference23 articles.

1. Mega JL, Close SL, Wiviott SD, Shen L (2009) Cytochrome P-450 polymorphisms and response to clopidogrel. N Engl J Med 360:354–362

2. Xie HG, Zou JJ, Hu ZY (2011) Individual variability in the disposition of and response to clopidogrel: pharmacogenomics and beyond. Pharmacol Ther 129:267–289

3. Simon T, Verstuyft C, Mary-Krause M (2009) Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 360:363–375

4. Kuliczkowski W, Witkowski A, Polonski L (2009) Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 30:426–435

5. Paré G, Mehta SR, Yusuf S (2010) Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med 363:1704–1714

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients;Open Medicine;2024-01-01

2. Research Progress on Related Genes of Clopidogrel Resistance;Advances in Clinical Medicine;2023

3. The efficacy of clopidogrel in preventing recurrent cardiovascular events among Arab population carrying different CYP2C19 mutations: systematic review and meta-analysis;Egyptian Journal of Medical Human Genetics;2022-06-11

4. The role of CYP2C19 gene polymorphisms on antiplatelet activity of clopidogrel among Arabs: systematic review and meta-analysis;2022-02-02

5. COX-1, COX-2 and CYP2C19 variations may be related to cardiovascular events due to acetylsalicylic acid resistance;Molecular Biology Reports;2022-01-09